AGP Executive Report
Last update: 3 hours agoClinical Research in Macau-linked Health: EyePoint says it has completed enrollment in two global Phase 3 trials (COMO and CAPRI) of DURAVYU™ for diabetic macular edema, enrolling over 480 patients in just five months, with topline 56-week data expected in 4Q 2027. Food Safety in Macau: Macau’s lead-flagged Frisolac Prestige infant formula case continues to ripple across the region; Macau health authorities say 13 samples show no abnormalities, while Hong Kong’s CFS reports stepped-up lead testing and no exceedances of its standard. Public Health & Research: UM hosted the Dr Stanley Ho Memorial Lecture on personalised cancer vaccines, featuring Oxford immuno-oncology expert Tim Elliott, as UM marks its 45th anniversary. Digital & AI Tech: Moonshot AI released Kimi K3, claiming it’s the largest-parameter open-source model globally (2.8T), with visual understanding and long context support. RegTech for Gaming: Macao Polytechnic University discusses how “smart tables” are moving beyond operations into regulatory technology for compliance and real-time oversight. Cross-border Infrastructure: Hong Kong and Shenzhen signed arrangements for Huanggang Port colocation, advancing shared port-area operations. Logistics & Connectivity: DHL launched its Shenzhen “super gateway,” boosting daily cargo capacity to 900 tonnes and aiming for more direct Asia-Pacific flights. Macau Policy & Governance: Commentary highlights Macau’s new government push for rule-of-law governance and administrative reform, while questioning how slogans translate into practical delivery.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.